1-1 of 1
Nishi Mehta
Close
Sort by
Journal Articles

NKX101, an Allogeneic Off-the-Shelf CAR NK Therapy Targeting NKG2D-Ls, Has Potent In Vitro Cytotoxicity Against Patient-Derived AML Leukemic Stem Cell (LSC) and Non-Leukemic Stem Cell (Non-LSC) Blasts

Kyle Hansen, Cynthia Cho, Nishi Mehta, David Shook, James Trager
Journal: Blood
Blood (2023) 142 (Supplement 1): 6844.
https://doi.org/10.1182/blood-2023-190214
Published: 2023